Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Rigel Pharmaceuticals, Inc. (RIGL) has a Wall Street consensus price target of $40.00, based on estimates from 15 covering analysts. With the stock currently trading at $34.74, this represents a potential upside of +15.1%. The company has a market capitalization of $615M.
Analyst price targets range from a low of $38.00 to a high of $42.00, representing a 10% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, RIGL trades at a trailing P/E of 35.1x and forward P/E of 8.8x. Analysts expect EPS to grow -32.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $302.23, with bear and bull scenarios of $-7574.40 and $208.73 respectively. Model confidence stands at 33/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how RIGL stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonRigel Pharmaceuticals, Inc. (RIGL) has a consensus 12-month price target of $40, implying 15.1% upside from $34.74. The 15 analysts covering RIGL see moderate appreciation potential.
RIGL has a consensus rating of "Buy" based on 15 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $40 implies 15.1% upside from current levels.
With a forward P/E of 8.7502x, RIGL trades at a relatively low valuation. The consensus target of $40 implies 15.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $42 for RIGL, while the most conservative target is $38. The consensus of $40 represents the median expectation. Our quantitative valuation model projects a bull case target of $209 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
RIGL is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month RIGL stock forecast based on 15 Wall Street analysts shows a consensus price target of $40, with estimates ranging from $38 (bear case) to $42 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $302, with bear/bull scenarios of $-7574/$209.
Our quantitative valuation model calculates RIGL's fair value at $302 (base case), with a bear case of $-7574 and bull case of $209. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 33/100.
RIGL trades at a forward P/E ratio of 8.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 35.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on RIGL, with a "Buy" consensus rating and $40 price target (15.1% upside). 8 of 15 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
RIGL analyst price targets range from $38 to $42, a 10% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40 consensus represents the middle ground. Our model's $-7574-$209 range provides an independent fundamental perspective.